MedPath
HSA Approval

POLYBAMYCIN OINT.

SIN04413P

POLYBAMYCIN OINT.

POLYBAMYCIN OINT.

May 3, 1990

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

OINTMENT

TOPICAL

Medical Information

D06AX04

neomycin

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

SHIN POONG PHARMACEUTICAL CO LTD

Active Ingredients

BACITRACIN

400 u/g

Bacitracin

POLYMYXIN B SULPHATE

5000 u/g

Polymyxin B

NEOMYCIN SULPHATE

3.5 mg/g

Neomycin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POLYBAMYCIN OINT. - HSA Approval | MedPath